Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 25, 2008

View Archived Issues

Recent Wonkisopharm patent reports novel therapeutic option for skin hyperpigmentation

Novel analgesic agents disclosed in recent patent literature

New therapeutic agents for neurological disorders reported in recent patents

Targeting the PI3K/Akt pathway beneficial against HIV infection

Positive preclinical results with staphylococcal enterotoxin B vaccine (STEBVax)

Acceleron and Celgene enter collaboration for ACE-011 cancer-related bone loss

Avexa initiates first test site for phase III trial of apricitabine for HIV

Sequenom reports encouraging results with noninvasive prenatal test for Down's syndrome

AGI Therapeutics reports key findings from pharmacokinetic study of Rezular

Sirtris enters agreement with the National Cancer Institute to test SIRT1 enzyme activators

Novel 5-HT6 receptor antagonist potentially useful as cognition enhancer

Allon Therapeutics adds Alzheimer's patients to ongoing phase II clinical trial of AL-108

PharmaIN received grant of USD 400,000 from the NIH for PGC-lysostaphin

Adherex receives FDA orphan drug designation for ADH-1 in melanoma

EMEA recommends marketing authorization of Ipsen's Adenuric

FDA grants priority review for prasugrel in acute coronary syndrome

ImClone Systems enrolls first patient in disease-directed phase II IMC-1121B trial

Sosei initiates a phase III trial for NorLevo

New oncolytic virus shows activity against brain and peripheral tumors

GSK receives CHMP positive opinion for Volibris

FDA to accelerate approval of Avastin plus paclitaxel as first-line breast cancer therapy

BioAlliance to acquire Immtech products despite pafuramidine program discontinuation

FDA approves Abbott's Humira for polyarticular juvenile idiopathic arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...